User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.

Primary tabs

Cruceru, Maria Linda Neagu, Monica Demoulin, Jean-Baptiste [UCL] Constantinescu, Stefan N. [UCL]

Despite intense efforts to identify cancer-initiating cells in malignant brain tumours, markers linked to the function of these cells have only very recently begun to be uncovered. The notion of cancer stem cell gained prominence, several molecules and signalling pathways becoming relevant for diagnosis and treatment. Whether a substantial fraction or only a tiny minority of cells in a tumor can initiate and perpetuate cancer, is still debated. The paradigm of cancer-initiating stem cells has initially been developed with respect to blood cancers where chronic conditions such as myeloproliferative neoplasms are due to mutations acquired in a haematopoietic stem cell (HSC), which maintains the normal hierarchy to neoplastic haematopoiesis. In contrast, acute leukaemia transformation of such blood neoplasms appears to derive not only from HSCs but also from committed progenitors that cannot differentiate. This review will focus on putative novel therapy targets represented by markers described to define cancer stem/initiating cells in malignant gliomas, which have been called 'leukaemia of the brain', given their rapid migration and evolution. Parallels are drawn with other cancers, especially haematopoietic, given the similar rampant proliferation and treatment resistance of glioblastoma multiforme and secondary acute leukaemias. Genes associated with the malignant conditions and especially expressed in glioma cancer stem cells are intensively searched. Although many such molecules might only coincidentally be expressed in cancer-initiating cells, some may function in the oncogenic process, and those would be the prime candidates for diagnostic and targeted therapy. For the latter, combination therapies are likely to be envisaged, given the robust and plastic signalling networks supporting malignant proliferation.

Document type Article de périodique (Journal article)
Access type Accès restreint
Publication date 2013
Language Anglais
Journal information "Journal of Cellular and Molecular Medicine" - Vol. 17, no.10, p. 1218-35 (2013)
Peer reviewed yes
Publisher Wiley-Blackwell Publishing Ltd. ((United Kingdom) Chichester)
issn 1582-4934
e-issn 1582-4934
Publication status Publié
Affiliation UCL - SSS/DDUV - Institut de Duve
Links
  1. Calabrese Christopher, Poppleton Helen, Kocak Mehmet, Hogg Twala L., Fuller Christine, Hamner Blair, Oh Eun Young, Gaber M. Waleed, Finklestein David, Allen Meredith, Frank Adrian, Bayazitov Ildar T., Zakharenko Stanislav S., Gajjar Amar, Davidoff Andrew, Gilbertson Richard J., A Perivascular Niche for Brain Tumor Stem Cells, 10.1016/j.ccr.2006.11.020
  2. Singh Sheila K., Hawkins Cynthia, Clarke Ian D., Squire Jeremy A., Bayani Jane, Hide Takuichiro, Henkelman R. Mark, Cusimano Michael D., Dirks Peter B., Identification of human brain tumour initiating cells, 10.1038/nature03128
  3. Taylor Michael D., Poppleton Helen, Fuller Christine, Su Xiaoping, Liu Yongxing, Jensen Patricia, Magdaleno Susan, Dalton James, Calabrese Christopher, Board Julian, MacDonald Tobey, Rutka Jim, Guha Abhijit, Gajjar Amar, Curran Tom, Gilbertson Richard J., Radial glia cells are candidate stem cells of ependymoma, 10.1016/j.ccr.2005.09.001
  4. Wu Anhua, Oh Seunguk, Wiesner Stephen M., Ericson Katya, Chen Lisa, Hall Walter A., Champoux Paul E., Low Walter C., Ohlfest John R., Persistence of CD133+Cells in Human and Mouse Glioma Cell Lines: Detailed Characterization of GL261 Glioma Cells with Cancer Stem Cell-Like Properties, 10.1089/scd.2007.0133
  5. Cheng Jin-Xiang, Liu Bo-Lin, Zhang Xiang, How powerful is CD133 as a cancer stem cell marker in brain tumors?, 10.1016/j.ctrv.2009.03.002
  6. Vainchenker W., Delhommeau F., Constantinescu S. N., Bernard O. A., New mutations and pathogenesis of myeloproliferative neoplasms, 10.1182/blood-2011-02-292102
  7. Bonnet Dominique, Dick John E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, 10.1038/nm0797-730
  8. Hope Kristin J, Jin Liqing, Dick John E, Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity, 10.1038/ni1080
  9. Notta Faiyaz, Mullighan Charles G., Wang Jean C. Y., Poeppl Armando, Doulatov Sergei, Phillips Letha A., Ma Jing, Minden Mark D., Downing James R., Dick John E., Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells, 10.1038/nature09733
  10. Driessens Gregory, Beck Benjamin, Caauwe Amélie, Simons Benjamin D., Blanpain Cédric, Defining the mode of tumour growth by clonal analysis, 10.1038/nature11344
  11. Riemenschneider Markus J., Jeuken Judith W. M., Wesseling Pieter, Reifenberger Guido, Molecular diagnostics of gliomas: state of the art, 10.1007/s00401-010-0736-4
  12. Pojo, Molecular targets of CNS tumors, 177 (2011)
  13. Crocetti Emanuele, Trama Annalisa, Stiller Charles, Caldarella Adele, Soffietti Riccardo, Jaal Jana, Weber Damien C., Ricardi Umberto, Slowinski Jerzy, Brandes Alba, Epidemiology of glial and non-glial brain tumours in Europe, 10.1016/j.ejca.2011.12.013
  14. Sato Atsushi, , Sakurada Kaori, Kumabe Toshihiro, Sasajima Toshio, Beppu Takaaki, Asano Kenichiro, Ohkuma Hiroki, Ogawa Akira, Mizoi Kazuo, Tominaga Teiji, Kitanaka Chifumi, Kayama Takamasa, Association of stem cell marker CD133 expression with dissemination of glioblastomas, 10.1007/s10143-010-0239-8
  15. Sharma Bhuvnesh K., Manglik Vinod, Elias E. George, Immuno-Expression of Human Melanoma Stem Cell Markers in Tissues at Different Stages of the Disease, 10.1016/j.jss.2010.03.043
  16. Boiko Alexander D., Razorenova Olga V., van de Rijn Matt, Swetter Susan M., Johnson Denise L., Ly Daphne P., Butler Paris D., Yang George P., Joshua Benzion, Kaplan Michael J., Longaker Michael T., Weissman Irving L., Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, 10.1038/nature09161
  17. Gilbert Candace A., Ross Alonzo H., Cancer stem cells: Cell culture, markers, and targets for new therapies, 10.1002/jcb.22350
  18. Sell Stewart, Cancer Stem Cells and Differentiation Therapy, 10.1159/000092323
  19. Yadirgi G, Marino S, Adult neural stem cells and their role in brain pathology, 10.1002/path.2480
  20. Hambardzumyan Dolores, Squatrito Massimo, Carbajal Eletha, Holland Eric C., Glioma Formation, Cancer Stem Cells, and Akt Signaling, 10.1007/s12015-008-9021-5
  21. Huang P. H., Xu A. M., White F. M., Oncogenic EGFR Signaling Networks in Glioma, 10.1126/scisignal.287re6
  22. Dalerba Piero, Kalisky Tomer, Sahoo Debashis, Rajendran Pradeep S, Rothenberg Michael E, Leyrat Anne A, Sim Sopheak, Okamoto Jennifer, Johnston Darius M, Qian Dalong, Zabala Maider, Bueno Janet, Neff Norma F, Wang Jianbin, Shelton Andrew A, Visser Brendan, Hisamori Shigeo, Shimono Yohei, van de Wetering Marc, Clevers Hans, Clarke Michael F, Quake Stephen R, Single-cell dissection of transcriptional heterogeneity in human colon tumors, 10.1038/nbt.2038
  23. Hamilton A., Helgason G. V., Schemionek M., Zhang B., Myssina S., Allan E. K., Nicolini F. E., Muller-Tidow C., Bhatia R., Brunton V. G., Koschmieder S., Holyoake T. L., Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival, 10.1182/blood-2010-12-326843
  24. Gambacorti-Passerini Carlo, Part I: Milestones in personalised medicine—imatinib, 10.1016/s1470-2045(08)70152-9
  25. Bengzon Johan, Englund Elisabet, Salford Leif G., Fan Xiaolong, Glioma Stem Cells in the Context of Oncogenesis, Stem Cells and Cancer (2009) ISBN:9781603279321 p.115-126, 10.1007/978-1-60327-933-8_9
  26. Altaner, Neoplasma, 55, 369 (2008)
  27. Morrison Sean J, Perez Sharon E, Qiao Zhou, Verdi Joseph M, Hicks Carol, Weinmaster Gerry, Anderson David J, Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells, 10.1016/s0092-8674(00)80860-0
  28. Rebetz Johan, Tian Dongping, Persson Annette, Widegren Bengt, Salford Leif G., Englund Elisabet, Gisselsson David, Fan Xiaolong, Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma, 10.1371/journal.pone.0001936
  29. Bachoo Robert M, Maher Elizabeth A, Ligon Keith L, Sharpless Norman E, Chan Suzanne S, You Mingjian James, Tang Yi, DeFrances Jessica, Stover Elizabeth, Weissleder Ralph, Rowitch David H, Louis David N, DePinho Ronald A, Epidermal growth factor receptor and Ink4a/Arf, 10.1016/s1535-6108(02)00046-6
  30. Jin X., Yin J., Kim S.-H., Sohn Y.-W., Beck S., Lim Y. C., Nam D.-H., Choi Y.-J., Kim H., EGFR-AKT-Smad Signaling Promotes Formation of Glioma Stem-like Cells and Tumor Angiogenesis by ID3-Driven Cytokine Induction, 10.1158/0008-5472.can-11-1330
  31. Jin Xun, Jin Xiong, Sohn Young-Woo, Yin Jinlong, Kim Sung-Hak, Joshi Kaushal, Nam Do-Hyun, Nakano Ichiro, Kim Hyunggee, Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression, 10.1016/j.canlet.2012.09.005
  32. Li Yunbo, Wang Dapeng, Wang Lei, Yu Jinhai, Du Danhua, Chen Ye, Gao Peng, Wang Duen-Mei, Yu Jun, Zhang Feng, Fu Shuanglin, Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients, 10.1371/journal.pone.0057168
  33. Verhaak Roel G.W., Hoadley Katherine A., Purdom Elizabeth, Wang Victoria, Qi Yuan, Wilkerson Matthew D., Miller C. Ryan, Ding Li, Golub Todd, Mesirov Jill P., Alexe Gabriele, Lawrence Michael, O'Kelly Michael, Tamayo Pablo, Weir Barbara A., Gabriel Stacey, Winckler Wendy, Gupta Supriya, Jakkula Lakshmi, Feiler Heidi S., Hodgson J. Graeme, James C. David, Sarkaria Jann N., Brennan Cameron, Kahn Ari, Spellman Paul T., Wilson Richard K., Speed Terence P., Gray Joe W., Meyerson Matthew, Getz Gad, Perou Charles M., Hayes D. Neil, Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1, 10.1016/j.ccr.2009.12.020
  34. Phillips Heidi S., Kharbanda Samir, Chen Ruihuan, Forrest William F., Soriano Robert H., Wu Thomas D., Misra Anjan, Nigro Janice M., Colman Howard, Soroceanu Liliana, Williams P. Mickey, Modrusan Zora, Feuerstein Burt G., Aldape Ken, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, 10.1016/j.ccr.2006.02.019
  35. Jamieson Catriona H.M., Ailles Laurie E., Dylla Scott J., Muijtjens Manja, Jones Carol, Zehnder James L., Gotlib Jason, Li Kevin, Manz Markus G., Keating Armand, Sawyers Charles L., Weissman Irving L., Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML, 10.1056/nejmoa040258
  36. Campbell P. J., Baxter E. J., Beer P. A., Scott L. M., Bench A. J., Huntly B. J. P., Erber W. N., Kusec R., Larsen T. S., Giraudier S., Le Bousse-Kerdiles M.-C., Griesshammer M., Reilly J. T., Cheung B. Y., Harrison C. N., Green A. R., Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation, 10.1182/blood-2005-12-013748
  37. Delhommeau F., Dupont S., Tonetti C., Masse A., Godin I., Couedic J.-P. L., Debili N., Saulnier P., Casadevall N., Vainchenker W., Giraudier S., Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis, 10.1182/blood-2006-03-007146
  38. Dykstra Brad, Kent David, Bowie Michelle, McCaffrey Lindsay, Hamilton Melisa, Lyons Kristin, Lee Shang-Jung, Brinkman Ryan, Eaves Connie, Long-Term Propagation of Distinct Hematopoietic Differentiation Programs In Vivo, 10.1016/j.stem.2007.05.015
  39. Muller-Sieburg, Blood, 100, 1302 (2002)
  40. Muller-Sieburg C. E., Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness, 10.1182/blood-2003-10-3448
  41. Challen Grant A., Boles Nathan C., Chambers Stuart M., Goodell Margaret A., Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1, 10.1016/j.stem.2010.02.002
  42. Taussig D. C., Miraki-Moud F., Anjos-Afonso F., Pearce D. J., Allen K., Ridler C., Lillington D., Oakervee H., Cavenagh J., Agrawal S. G., Lister T. A., Gribben J. G., Bonnet D., Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells, 10.1182/blood-2007-10-118331
  43. Jaras M., Johnels P., Hansen N., Agerstam H., Tsapogas P., Rissler M., Lassen C., Olofsson T., Bjerrum O. W., Richter J., Fioretos T., Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein, 10.1073/pnas.1004408107
  44. Barreyro L., Will B., Bartholdy B., Zhou L., Todorova T. I., Stanley R. F., Ben-Neriah S., Montagna C., Parekh S., Pellagatti A., Boultwood J., Paietta E., Ketterling R. P., Cripe L., Fernandez H. F., Greenberg P. L., Tallman M. S., Steidl C., Mitsiades C. S., Verma A., Steidl U., Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS, 10.1182/blood-2012-01-404699
  45. Vainchenker W, Constantinescu S N, JAK/STAT signaling in hematological malignancies, 10.1038/onc.2012.347
  46. Welch John S., Ley Timothy J., Link Daniel C., Miller Christopher A., Larson David E., Koboldt Daniel C., Wartman Lukas D., Lamprecht Tamara L., Liu Fulu, Xia Jun, Kandoth Cyriac, Fulton Robert S., McLellan Michael D., Dooling David J., Wallis John W., Chen Ken, Harris Christopher C., Schmidt Heather K., Kalicki-Veizer Joelle M., Lu Charles, Zhang Qunyuan, Lin Ling, O’Laughlin Michelle D., McMichael Joshua F., Delehaunty Kim D., Fulton Lucinda A., Magrini Vincent J., McGrath Sean D., Demeter Ryan T., Vickery Tammi L., Hundal Jasreet, Cook Lisa L., Swift Gary W., Reed Jerry P., Alldredge Patricia A., Wylie Todd N., Walker Jason R., Watson Mark A., Heath Sharon E., Shannon William D., Varghese Nobish, Nagarajan Rakesh, Payton Jacqueline E., Baty Jack D., Kulkarni Shashikant, Klco Jeffery M., Tomasson Michael H., Westervelt Peter, Walter Matthew J., Graubert Timothy A., DiPersio John F., Ding Li, Mardis Elaine R., Wilson Richard K., The Origin and Evolution of Mutations in Acute Myeloid Leukemia, 10.1016/j.cell.2012.06.023
  47. Ignatova Tatyana N., Kukekov Valery G., Laywell Eric D., Suslov Oleg N., Vrionis Frank D., Steindler Dennis A., Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro, 10.1002/glia.10094
  48. Hemmati H. D., Nakano I., Lazareff J. A., Masterman-Smith M., Geschwind D. H., Bronner-Fraser M., Kornblum H. I., Cancerous stem cells can arise from pediatric brain tumors, 10.1073/pnas.2036535100
  49. Lee Jeongwu, Kotliarova Svetlana, Kotliarov Yuri, Li Aiguo, Su Qin, Donin Nicholas M., Pastorino Sandra, Purow Benjamin W., Christopher Neil, Zhang Wei, Park John K., Fine Howard A., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, 10.1016/j.ccr.2006.03.030
  50. Singh, Cancer Res, 63, 5821 (2003)
  51. Zaidi Hasan A., Kosztowski Thomas, DiMeco Francesco, Quiñones-Hinojosa Alfredo, Origins and clinical implications of the brain tumor stem cell hypothesis, 10.1007/s11060-009-9856-x
  52. Galli Rossella, Binda Elena, Orfanelli Ugo, Cipelletti Barbara, Gritti Angela, De Vitis Simona, Fiocco Roberta, Foroni Chiara, Dimeco Francesco, Vescovi Angelo, Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma, 10.1158/0008-5472.can-04-1364
  53. Hambardzumyan D., Becher O. J., Rosenblum M. K., Pandolfi P. P., Manova-Todorova K., Holland E. C., PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo, 10.1101/gad.1627008
  54. Qian Hong, Buza-Vidas Natalija, Hyland Craig D., Jensen Christina T., Antonchuk Jennifer, Månsson Robert, Thoren Lina A., Ekblom Marja, Alexander Warren S., Jacobsen Sten Eirik W., Critical Role of Thrombopoietin in Maintaining Adult Quiescent Hematopoietic Stem Cells, 10.1016/j.stem.2007.10.008
  55. Yoshihara Hiroki, Arai Fumio, Hosokawa Kentaro, Hagiwara Tetsuya, Takubo Keiyo, Nakamura Yuka, Gomei Yumiko, Iwasaki Hiroko, Matsuoka Sahoko, Miyamoto Kana, Miyazaki Hiroshi, Takahashi Takao, Suda Toshio, Thrombopoietin/MPL Signaling Regulates Hematopoietic Stem Cell Quiescence and Interaction with the Osteoblastic Niche, 10.1016/j.stem.2007.10.020
  56. de Graaf C. A., Kauppi M., Baldwin T., D. Hyland C., Metcalf D., Willson T. A., Carpinelli M. R., Smyth G. K., Alexander W. S., Hilton D. J., Regulation of hematopoietic stem cells by their mature progeny, 10.1073/pnas.1016166108
  57. Abkowitz J. L., Chen J., Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones, 10.1182/blood-2006-08-044503
  58. Wicha Max S, Cancer stem cell heterogeneity in hereditary breast cancer, 10.1186/bcr1990
  59. Wright Mollie H, Calcagno Anna Maria, Salcido Crystal D, Carlson Marisa D, Ambudkar Suresh V, Varticovski Lyuba, Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics, 10.1186/bcr1855
  60. Gömöri Éva, Pál József, Kovács Bernadett, Dóczi Tamás, Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas, 10.1186/1746-1596-7-8
  61. Ahmadi Rezvan, Stockhammer Florian, Becker Natalia, Hohlen Katarina, Misch Martin, Christians Arne, Dictus Christine, Herold-Mende Christel, Capper David, Unterberg Andreas, von Deimling Andreas, Wick Wolfgang, Hartmann Christian, No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas, 10.1007/s11060-012-0863-y
  62. Juratli Tareq A., Kirsch Matthias, Robel Katja, Soucek Silke, Geiger Kathrin, von Kummer Rüdiger, Schackert Gabriele, Krex Dietmar, IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas, 10.1007/s11060-012-0844-1
  63. Bao Shideng, Wu Qiulian, McLendon Roger E., Hao Yueling, Shi Qing, Hjelmeland Anita B., Dewhirst Mark W., Bigner Darell D., Rich Jeremy N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, 10.1038/nature05236
  64. Liu Gentao, Yuan Xiangpeng, Zeng Zhaohui, Tunici Patrizia, Ng Hiushan, Abdulkadir Iman R, Lu Lizhi, Irvin Dwain, Black Keith L, Yu John S, 10.1186/1476-4598-5-67
  65. Strojnik Tadej, Røsland Gro Vatne, Sakariassen Per Oystein, Kavalar Rajko, Lah Tamara, Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival, 10.1016/j.surneu.2006.10.050
  66. Thon Niklas, Damianoff Karin, Hegermann Jemima, Grau Stefan, Krebs Bjarne, Schnell Oliver, Tonn Jörg-Christian, Goldbrunner Roland, Presence of pluripotent CD133+ cells correlates with malignancy of gliomas, 10.1016/j.mcn.2008.07.022
  67. Beier Dagmar, Wischhusen Jörg, Dietmaier Wolfgang, Hau Peter, Proescholdt Martin, Brawanski Alexander, Bogdahn Ulrich, Beier Christoph P., CD133 Expression and Cancer Stem Cells Predict Prognosis in High-grade Oligodendroglial Tumors, 10.1111/j.1750-3639.2008.00130.x
  68. Arai Fumio, Hosokawa Kentaro, Toyama Hirofumi, Matsumoto Yoshiko, Suda Toshio, Role of N-cadherin in the regulation of hematopoietic stem cells in the bone marrow niche : Function of N-cadherin in the regulation of HSPCs, 10.1111/j.1749-6632.2012.06576.x
  69. Lataillade, Med Sci, 26, 582 (2010)
  70. Ricci-Vitiani Lucia, Pallini Roberto, Biffoni Mauro, Todaro Matilde, Invernici Gloria, Cenci Tonia, Maira Giulio, Parati Eugenio Agostino, Stassi Giorgio, Larocca Luigi Maria, De Maria Ruggero, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, 10.1038/nature09557
  71. Soda Y., Marumoto T., Friedmann-Morvinski D., Soda M., Liu F., Michiue H., Pastorino S., Yang M., Hoffman R. M., Kesari S., Verma I. M., Transdifferentiation of glioblastoma cells into vascular endothelial cells, 10.1073/pnas.1016030108
  72. Sozer Selcuk, Hoffman Ronald, Laser-Capture Microdissection and Analysis of Liver Endothelial Cells from Patients with Budd–Chiari Syndrome, Methods in Molecular Biology (2011) ISBN:9781617791628 p.405-415, 10.1007/978-1-61779-163-5_34
  73. Reynolds B., Weiss S, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, 10.1126/science.1553558
  74. Walker MR, Patel KK, Stappenbeck TS, The stem cell niche, 10.1002/path.2474
  75. Naveiras O., Daley G. Q., Stem cells and their niche: a matter of fate, 10.1007/s00018-005-5469-5
  76. Karpowicz P., Willaime-Morawek S., Balenci L., DeVeale B., Inoue T., van der Kooy D., E-Cadherin Regulates Neural Stem Cell Self-Renewal, 10.1523/jneurosci.0037-09.2009
  77. Sanai Nader, Alvarez-Buylla Arturo, Berger Mitchel S., Neural Stem Cells and the Origin of Gliomas, 10.1056/nejmra043666
  78. Pérez-Castillo Ana, Aguilar-Morante Diana, Morales-García José A., Dorado Jorge, Cancer stem cells and brain tumors, 10.1007/s12094-008-0195-8
  79. Croker A.K, Allan A.L, Cancer stem cells: implications for the progression and treatment of metastatic disease, 10.1111/j.1582-4934.2007.00211.x
  80. Miraglia, Blood, 90, 5013 (1997)
  81. Fargeas C. A., Huttner W. B., Corbeil D., Nomenclature of prominin-1 (CD133) splice variants ? an update, 10.1111/j.1399-0039.2007.00825.x
  82. McCord A. M., Jamal M., Williams E. S., Camphausen K., Tofilon P. J., CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines, 10.1158/1078-0432.ccr-09-0263
  83. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P. J., Aigner L., Brawanski A., Bogdahn U., Beier C. P., CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles, 10.1158/0008-5472.can-06-4180
  84. Singh Sheila K, Clarke Ian D, Hide Takuichiro, Dirks Peter B, Cancer stem cells in nervous system tumors, 10.1038/sj.onc.1207946
  85. Yuan Xiangpeng, Curtin James, Xiong Yizhi, Liu Gentao, Waschsmann-Hogiu Sebastian, Farkas Daniel L, Black Keith L, Yu John S, Isolation of cancer stem cells from adult glioblastoma multiforme, 10.1038/sj.onc.1208311
  86. Lottaz C., Beier D., Meyer K., Kumar P., Hermann A., Schwarz J., Junker M., Oefner P. J., Bogdahn U., Wischhusen J., Spang R., Storch A., Beier C. P., Transcriptional Profiles of CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin, 10.1158/0008-5472.can-09-1707
  87. Joo Kyeung Min, Kim Shi Yean, Jin Xun, Song Sang Yong, Kong Doo-Sik, Lee Jung-II, Jeon Ji Won, Kim Mi Hyun, Kang Bong Gu, Jung Yong, Jin Juyoun, Hong Seung-Chyul, Park Woong-Yang, Lee Dong-Sup, Kim Hyunggee, Nam Do-Hyun, Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas, 10.1038/labinvest.2008.57
  88. Clément Virginie, Dutoit Valérie, Marino Denis, Dietrich Pierre-Yves, Radovanovic Ivan, Limits of CD133 as a marker of glioma self-renewing cells, 10.1002/ijc.24352
  89. Zeppernick F., Ahmadi R., Campos B., Dictus C., Helmke B. M., Becker N., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C. C., Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients, 10.1158/1078-0432.ccr-07-0932
  90. Murat Anastasia, Migliavacca Eugenia, Gorlia Thierry, Lambiv Wanyu L., Shay Tal, Hamou Marie-France, de Tribolet Nicolas, Regli Luca, Wick Wolfgang, Kouwenhoven Mathilde C.M., Hainfellner Johannes A., Heppner Frank L., Dietrich Pierre-Yves, Zimmer Yitzhak, Cairncross J. Gregory, Janzer Robert-Charles, Domany Eytan, Delorenzi Mauro, Stupp Roger, Hegi Monika E., Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma, 10.1200/jco.2007.15.7164
  91. Wang Jian, Sakariassen Per Ø., Tsinkalovsky Oleg, Immervoll Heike, Bøe Stig Ove, Svendsen Agnete, Prestegarden Lars, Røsland Gro, Thorsen Frits, Stuhr Linda, Molven Anders, Bjerkvig Rolf, Enger Per Ø., CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells, 10.1002/ijc.23130
  92. Pallini R., Ricci-Vitiani L., Banna G. L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L. M., De Maria R., Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme, 10.1158/1078-0432.ccr-08-0644
  93. Kato Hideaki, Fujimura Miki, Kumabe Toshihiro, Ishioka Chikashi, Kanamaru Ryunosuke, Yoshimoto Takashi, PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma, 10.1016/j.jocn.2002.09.001
  94. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay R D, Engh J, Iwama T, Kunisada T, Kassam A B, Pollack I F, Park D M, Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α, 10.1038/onc.2009.252
  95. Xu Q, Yuan X, Tunici P, Liu G, Fan X, Xu M, Hu J, Hwang J Y, Farkas D L, Black K L, Yu J S, Isolation of tumour stem-like cells from benign tumours, 10.1038/sj.bjc.6605142
  96. Zhang Mingyu, Song Tao, Yang Liang, Chen Ruokun, Wu Lei, Yang Zhuanyi, Fang Jiasheng, Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients, 10.1186/1756-9966-27-85
  97. He, Oncol Rep, 27, 45 (2012)
  98. Ma Yue-Hui, Mentlein Rolf, Knerlich Friederike, Kruse Marie-Luise, Mehdorn H. Maximilian, Held-Feindt Janka, Expression of stem cell markers in human astrocytomas of different WHO grades, 10.1007/s11060-007-9439-7
  99. Dell’Albani Paola, Stem Cell Markers in Gliomas, 10.1007/s11064-008-9723-8
  100. deCarvalho, Stem Cells, 28, 181 (2010)
  101. Toda Masahiro, Iizuka Yukihiko, Yu Wangjie, Imai Takao, Ikeda Eiji, Yoshida Kazunari, Kawase Takeshi, Kawakami Yutaka, Okano Hideyuki, Uyemura Keiichi, Expression of the neural RNA-binding protein Musashi1 in human gliomas, 10.1002/glia.1034
  102. Jackson Erica L., Garcia-Verdugo Jose Manuel, Gil-Perotin Sara, Roy Monica, Quinones-Hinojosa Alfredo, VandenBerg Scott, Alvarez-Buylla Arturo, PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling, 10.1016/j.neuron.2006.06.012
  103. Peñuelas Silvia, Anido Judit, Prieto-Sánchez Rosa M., Folch Gerard, Barba Ignasi, Cuartas Isabel, García-Dorado David, Poca M. Antonia, Sahuquillo Juan, Baselga Jose, Seoane Joan, TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma, 10.1016/j.ccr.2009.02.011
  104. Ito Takahiro, Kwon Hyog Young, Zimdahl Bryan, Congdon Kendra L., Blum Jordan, Lento William E., Zhao Chen, Lagoo Anand, Gerrard Gareth, Foroni Letizia, Goldman John, Goh Harriet, Kim Soo-Hyun, Kim Dong-Wook, Chuah Charles, Oehler Vivian G., Radich Jerald P., Jordan Craig T., Reya Tannishtha, Regulation of myeloid leukaemia by the cell-fate determinant Musashi, 10.1038/nature09171
  105. Fotovati A., Abu-Ali S., Wang P.-S., Deleyrolle L. P., Lee C., Triscott J., Chen J. Y., Franciosi S., Nakamura Y., Sugita Y., Uchiumi T., Kuwano M., Leavitt B. R., Singh S. K., Jury A., Jones C., Wakimoto H., Reynolds B. A., Pallen C. J., Dunn S. E., YB-1 Bridges Neural Stem Cells and Brain Tumor-Initiating Cells via Its Roles in Differentiation and Cell Growth, 10.1158/0008-5472.can-10-2805
  106. Muto Jun, Imai Takao, Ogawa Daisuke, Nishimoto Yoshinori, Okada Yohei, Mabuchi Yo, Kawase Takeshi, Iwanami Akio, Mischel Paul S., Saya Hideyuki, Yoshida Kazunari, Matsuzaki Yumi, Okano Hideyuki, RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways, 10.1371/journal.pone.0033431
  107. Guo Yuji, Liu Shangming, Wang Ping, Zhao Shidou, Wang Fuwu, Bing Lujun, Zhang Yanmin, Ling Eng-Ang, Gao Jiangang, Hao Aijun, Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas : Oct4 and Sox2 and Nanog in human gliomas, 10.1111/j.1365-2559.2011.03993.x
  108. Takahashi Kazutoshi, Yamanaka Shinya, Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, 10.1016/j.cell.2006.07.024
  109. Buganim Yosef, Faddah Dina A., Cheng Albert W., Itskovich Elena, Markoulaki Styliani, Ganz Kibibi, Klemm Sandy L., van Oudenaarden Alexander, Jaenisch Rudolf, Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase, 10.1016/j.cell.2012.08.023
  110. Ikushima Hiroaki, Todo Tomoki, Ino Yasushi, Takahashi Masamichi, Miyazawa Keiji, Miyazono Kohei, Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors, 10.1016/j.stem.2009.08.018
  111. Gangemi Rosaria Maria Rita, Griffero Fabrizio, Marubbi Daniela, Perera Marzia, Capra Maria Cristina, Malatesta Paolo, Ravetti Gian Luigi, Zona Gian Luigi, Daga Antonio, Corte Giorgio, SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity, 10.1634/stemcells.2008-0493
  112. Marie Suely K.N., Okamoto Oswaldo K., Uno Miyuki, Hasegawa Ana Paula G., Oba-Shinjo Sueli M., Cohen Tzeela, Camargo Anamaria A., Kosoy Ana, Carlotti Carlos G., Toledo Silvia, Moreira-Filho Carlos A., Zago Marco A., Simpson Andrew J., Caballero Otavia L., Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas, 10.1002/ijc.23189
  113. Nakano Ichiro, Kornblum Harley I., Methods for Analysis of Brain Tumor Stem Cell and Neural Stem Cell Self-Renewal, Methods in Molecular Biology (2009) ISBN:9781588299383 p.37-56, 10.1007/978-1-59745-280-9_4
  114. Yoshimoto Koji, Ma Xinlong, Guan Yaulei, Mizoguchi Masahiro, Nakamizo Akira, Amano Toshiyuki, Hata Nobuhiro, Kuga Daisuke, Sasaki Tomio, Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR, 10.1007/s10014-011-0046-0
  115. Cheng Lin, Bao Shideng, Rich Jeremy N., Potential therapeutic implications of cancer stem cells in glioblastoma, 10.1016/j.bcp.2010.04.035
  116. Vanhaesebroeck Bart, Stephens Len, Hawkins Phillip, PI3K signalling: the path to discovery and understanding, 10.1038/nrm3290
  117. Molina Jennifer R., Hayashi Yuho, Stephens Clifton, Georgescu Maria-Magdalena, Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation, 10.1593/neo.10126
  118. Amit Ido, Wides Ron, Yarden Yosef, Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy, 10.1038/msb4100195
  119. Fan Q.-W., Cheng C., Knight Z. A., Haas-Kogan D., Stokoe D., James C. D., McCormick F., Shokat K. M., Weiss W. A., EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma, 10.1126/scisignal.2000014
  120. Dang M., Armbruster N., Miller M. A., Cermeno E., Hartmann M., Bell G. W., Root D. E., Lauffenburger D. A., Lodish H. F., Herrlich A., Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways, 10.1073/pnas.1307478110
  121. Wen P. Y., Lee E. Q., Reardon D. A., Ligon K. L., Alfred Yung W. K., Current clinical development of PI3K pathway inhibitors in glioblastoma, 10.1093/neuonc/nos117
  122. Cheng C. K., Gustafson W. C., Charron E., Houseman B. T., Zunder E., Goga A., Gray N. S., Pollok B., Oakes S. A., James C. D., Shokat K. M., Weiss W. A., Fan Q.-W., Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma, 10.1073/pnas.1202492109
  123. Vannucchi, Blood (ASH Annual Meeting Abstracts), 120 (2012)
  124. Choong, Blood (ASH Annual Meeting Abstracts), 120 (2012)
  125. Guglielmelli P., Barosi G., Rambaldi A., Marchioli R., Masciulli A., Tozzi L., Biamonte F., Bartalucci N., Gattoni E., Lupo M. L., Finazzi G., Pancrazzi A., Antonioli E., Susini M. C., Pieri L., Malevolti E., Usala E., Occhini U., Grossi A., Caglio S., Paratore S., Bosi A., Barbui T., Vannucchi A. M., , Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis, 10.1182/blood-2011-01-330563
  126. Inda M.-d.-M., Bonavia R., Mukasa A., Narita Y., Sah D. W. Y., Vandenberg S., Brennan C., Johns T. G., Bachoo R., Hadwiger P., Tan P., DePinho R. A., Cavenee W., Furnari F., Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma, 10.1101/gad.1890510
  127. Fenton T. R., Nathanson D., Ponte de Albuquerque C., Kuga D., Iwanami A., Dang J., Yang H., Tanaka K., Oba-Shinjo S. M., Uno M., del Mar Inda M., Wykosky J., Bachoo R. M., James C. D., DePinho R. A., Vandenberg S. R., Zhou H., Marie S. K. N., Mischel P. S., Cavenee W. K., Furnari F. B., Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240, 10.1073/pnas.1211962109
  128. Hatanpaa Kimmo J., Burma Sandeep, Zhao Dawen, Habib Amyn A., Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance, 10.1593/neo.10688
  129. Liu Yan, Elf Shannon E., Miyata Yasuhiko, Sashida Goro, Liu Yuhui, Huang Gang, Di Giandomenico Silvana, Lee Jennifer M., Deblasio Anthony, Menendez Silvia, Antipin Jack, Reva Boris, Koff Andrew, Nimer Stephen D., p53 Regulates Hematopoietic Stem Cell Quiescence, 10.1016/j.stem.2008.11.006
  130. Billottet C., Banerjee L., Vanhaesebroeck B., Khwaja A., Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation, 10.1158/0008-5472.can-08-2608
  131. Ringshausen I., Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta, 10.1182/blood-2002-02-0539
  132. Sujobert P., Essential role for the p110  isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia, 10.1182/blood-2004-08-3225
  133. Nazarenko Inga, Hede Sanna-Maria, He Xiaobing, Hedrén Anna, Thompson James, Lindström Mikael S., Nistér Monica, PDGF and PDGF receptors in glioma, 10.3109/03009734.2012.665097
  134. Uhrbom, Cancer Res, 58, 5275 (1998)
  135. Reardon D A, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Blomquist E, Gordower L, Schultz H, Raizer J, Hau P, Easaw J, Gil M, Tonn J, Gijtenbeek A, Schlegel U, Bergstrom P, Green S, Weir A, Nikolova Z, Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma, 10.1038/sj.bjc.6605411
  136. Paulsson Janna, Lindh Maja Bradic, Jarvius Malin, Puputti Marjut, Nistér Monica, Nupponen Nina N., Paulus Werner, Söderberg Ola, Dresemann Gregor, von Deimling Andreas, Joensuu Heikki, Östman Arne, Hasselblatt Martin, Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma, 10.1002/ijc.25528
  137. Toffalini F., Demoulin J.-B., New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases, 10.1182/blood-2010-04-279752
  138. Shih Alan H., Holland Eric C., Notch Signaling Enhances Nestin Expression in Gliomas, 10.1593/neo.06526
  139. Tchorz J S, Tome M, Cloëtta D, Sivasankaran B, Grzmil M, Huber R M, Rutz-Schatzmann F, Kirchhoff F, Schaeren-Wiemers N, Gassmann M, Hemmings B A, Merlo A, Bettler B, Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry, 10.1038/cddis.2012.65
  140. Fan, Stem Cells, 28, 5 (2010)
  141. Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin C R, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S, Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition, 10.1038/onc.2011.58
  142. Zeng Qinghua, Li Shenglin, Chepeha Douglas B., Giordano Thomas J., Li Jong, Zhang Honglai, Polverini Peter J., Nor Jacques, Kitajewski Jan, Wang Cun-Yu, Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling, 10.1016/j.ccr.2005.06.004
  143. Yan M., Plowman G. D., Delta-like 4/Notch Signaling and Its Therapeutic Implications, 10.1158/1078-0432.ccr-07-1393
  144. Li J.-L., Sainson R. C.A., Shi W., Leek R., Harrington L. S., Preusser M., Biswas S., Turley H., Heikamp E., Hainfellner J. A., Harris A. L., Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo, 10.1158/0008-5472.can-07-0969
  145. Anido Judit, Sáez-Borderías Andrea, Gonzàlez-Juncà Alba, Rodón Laura, Folch Gerard, Carmona Maria A., Prieto-Sánchez Rosa M., Barba Ignasi, Martínez-Sáez Elena, Prudkin Ludmila, Cuartas Isabel, Raventós Carolina, Martínez-Ricarte Francisco, Poca M. Antonia, García-Dorado David, Lahn Michael M., Yingling Jonathan M., Rodón Jordi, Sahuquillo Juan, Baselga José, Seoane Joan, TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma, 10.1016/j.ccr.2010.10.023
  146. Schneider Thomas, Sailer Michael, Ansorge Siegfried, Firsching Raimund, Reinhold Dirk, Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma, 10.1007/s11060-005-9116-7
  147. Qiu Bo, Zhang Dongyong, Wang Chao, Tao Jun, Tie Xinxin, Qiao Ying, Xu Ke, Wang Yunjie, Wu Anhua, IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas, 10.1007/s11033-010-0469-4
  148. Bruna Alejandra, Darken Rachel S., Rojo Federico, Ocaña Alberto, Peñuelas Silvia, Arias Alexandra, Paris Raquel, Tortosa Avelina, Mora Jaume, Baselga Jose, Seoane Joan, High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B Gene, 10.1016/j.ccr.2006.11.023
  149. Jin S.-G., Jiang Y., Qiu R., Rauch T. A., Wang Y., Schackert G., Krex D., Lu Q., Pfeifer G. P., 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations, 10.1158/0008-5472.can-11-2023
  150. Piccirillo S. G. M., Reynolds B. A., Zanetti N., Lamorte G., Binda E., Broggi G., Brem H., Olivi A., Dimeco F., Vescovi A. L., Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, 10.1038/nature05349
  151. Mehler Mark F., Mabie Peter C., Zhu Gaofa, Gokhan Solen, Kessler John A., Developmental Changes in Progenitor Cell Responsiveness to Bone Morphogenetic Proteins Differentially Modulate Progressive CNS Lineage Fate, 10.1159/000017429
  152. Yamada N, Kato M, ten Dijke P, Yamashita H, Sampath TK, Heldin C-H, Miyazono K, Funa K, Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours, 10.1038/bjc.1996.108
  153. Xu Qijin, Yuan Xiangpeng, Liu Gentao, Black Keith L., Yu John S., Hedgehog Signaling Regulates Brain Tumor-Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas : HEDGEHOG SIGNALING REGULATES BRAIN TUMOR-INITIATING CELL PROLIFERATION AND PORTENDS SHORTER SURVIVAL FOR PATIENTS WITH PTEN-COEXPRESSING GLIOBLASTOMAS, 10.1634/stemcells.2008-0459
  154. Clement Virginie, Sanchez Pilar, de Tribolet Nicolas, Radovanovic Ivan, Ruiz i Altaba Ariel, HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity, 10.1016/j.cub.2006.11.033
  155. Bar Eli E., Chaudhry Aneeka, Lin Alex, Fan Xing, Schreck Karisa, Matsui William, Piccirillo Sara, Vescovi Angelo L., DiMeco Francesco, Olivi Alessandro, Eberhart Charles G., Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma, 10.1634/stemcells.2007-0166
  156. Takezaki Tatsuya, Hide Takuichiro, Takanaga Hiromi, Nakamura Hideo, Kuratsu Jun-ichi, Kondo Toru, Essential role of the Hedgehog signaling pathway in human glioma-initiating cells, 10.1111/j.1349-7006.2011.01943.x
  157. Fodde Riccardo, Brabletz Thomas, Wnt/β-catenin signaling in cancer stemness and malignant behavior, 10.1016/j.ceb.2007.02.007
  158. Kim Yonghyun, Kim Kang Ho, Lee Jeena, Lee Young-Ae, Kim Misuk, Lee Se Jeong, Park Kernyu, Yang Heekyoung, Jin Juyoun, Joo Kyeung Min, Lee Jeongwu, Nam Do-Hyun, Wnt activation is implicated in glioblastoma radioresistance, 10.1038/labinvest.2011.161
  159. Kahlert Ulf D., Maciaczyk Donata, Doostkam Soroush, Orr Brent A., Simons Brian, Bogiel Tomasz, Reithmeier Thomas, Prinz Marco, Schubert Jörg, Niedermann Gabriele, Brabletz Thomas, Eberhart Charles G., Nikkhah Guido, Maciaczyk Jaroslaw, Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition, 10.1016/j.canlet.2012.05.024
  160. Seubert Nadine, Royer Yohan, Staerk Judith, Kubatzky Katharina F, Moucadel Virginie, Krishnakumar Shyam, Smith Steven O, Constantinescu Stefan N, Active and Inactive Orientations of the Transmembrane and Cytosolic Domains of the Erythropoietin Receptor Dimer, 10.1016/s1097-2765(03)00389-7
  161. Constantinescu Stefan N., Ghaffari Saghi, Lodish Harvey F., The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction, 10.1016/s1043-2760(98)00101-5
  162. Darnell J., Kerr I., Stark G., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, 10.1126/science.8197455
  163. la Iglesia Nuria, Puram Sidharth, Bonni Azad, STAT3 Regulation of Glioblastoma Pathogenesis, 10.2174/156652409788488739
  164. Sherry Maureen M., Reeves Andrew, Wu Julian K., Cochran Brent H., STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells, 10.1002/stem.185
  165. Cooper Lee A.D., Gutman David A., Chisolm Candace, Appin Christina, Kong Jun, Rong Yuan, Kurc Tahsin, Van Meir Erwin G., Saltz Joel H., Moreno Carlos S., Brat Daniel J., The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma, 10.1016/j.ajpath.2012.01.040
  166. Sai Ke, Wang Shuzhen, Balasubramaniyan Veerakumar, Conrad Charles, Lang Frederick F., Aldape Kenneth, Szymanski Slawomir, Fokt Izabela, Dasgupta Atreyi, Madden Timothy, Guan Su, Chen Zhongping, Alfred Yung W. K., Priebe Waldemar, Colman Howard, Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway, 10.1007/s11060-011-0786-z
  167. Nilsson Carol L., Dillon Roslyn, Devakumar Arugadoss, Shi Stone D.-H., Greig Michael, Rogers John C., Krastins Bryan, Rosenblatt Michael, Kilmer Gregory, Major Michael, Kaboord Barbara J., Sarracino David, Rezai Taha, Prakash Amol, Lopez Mary, Ji Yongjie, Priebe Waldemar, Lang Frederick F., Colman Howard, Conrad Charles A., Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells, 10.1021/pr9007927
  168. Debinski, Int J Oncol, 15, 481 (1999)
  169. Mintz Akiva, Gibo Denise M., Slagle-Webb Becky, Christensent Neil D., Debinski Waldemar, IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13, 10.1038/sj.neo.7900234
  170. Kunwar S., Chang S., Westphal M., Vogelbaum M., Sampson J., Barnett G., Shaffrey M., Ram Z., Piepmeier J., Prados M., Croteau D., Pedain C., Leland P., Husain S. R., Joshi B. H., Puri R. K., , Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma, 10.1093/neuonc/nop054
  171. Kioi Mitomu, Kawakami Mariko, Shimamura Takeshi, Husain Syed R., Puri Raj K., Interleukin-13 receptor α2 chain : A potential biomarker and molecular target for ovarian cancer therapy, 10.1002/cncr.22134
  172. Caput Daniel, Laurent Patrick, Kaghad Mourad, Lelias Jean-Michel, Lefort Sylvie, Vita Natalio, Ferrara Pascual, Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α Chain, 10.1074/jbc.271.28.16921
  173. Lupardus Patrick J., Birnbaum Michael E., Garcia K. Christopher, Molecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2, 10.1016/j.str.2010.01.003
  174. Donaldson, J Immunol, 161, 2317 (1998)
  175. Fichtner-Feigl Stefan, Strober Warren, Kawakami Koji, Puri Raj K, Kitani Atsushi, IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis, 10.1038/nm1332
  176. Rahaman Shaik Ohidar, Vogelbaum Michael A., Haque S. Jaharul, Aberrant Stat3 Signaling by Interleukin-4 in Malignant Glioma Cells: Involvement of IL-13Rα2, 10.1158/0008-5472.can-04-3592
  177. Mandal Debasmita, Levine Alan D., Elevated IL-13Rα2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway : , 10.1002/ibd.21133
  178. Latha Khatri, Li Ming, Chumbalkar Vaibhav, Gururaj Anupama, Hwang YeoHyeon, Dakeng Sumana, Sawaya Raymond, Aldape Kenneth, Cavenee Webster K., Bogler Oliver, Furnari Frank B., Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter, 10.1002/ijc.27690
  179. Flex Elisabetta, Petrangeli Valentina, Stella Lorenzo, Chiaretti Sabina, Hornakova Tekla, Knoops Laurent, Ariola Cristina, Fodale Valentina, Clappier Emmanuelle, Paoloni Francesca, Martinelli Simone, Fragale Alessandra, Sanchez Massimo, Tavolaro Simona, Messina Monica, Cazzaniga Giovanni, Camera Andrea, Pizzolo Giovanni, Tornesello Assunta, Vignetti Marco, Battistini Angela, Cavé Hélène, Gelb Bruce D., Renauld Jean-Christophe, Biondi Andrea, Constantinescu Stefan N., Foà Robin, Tartaglia Marco, Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia, 10.1084/jem.20072182
  180. Jeong E. G., Kim M. S., Nam H. K., Min C. K., Lee S., Chung Y. J., Yoo N. J., Lee S. H., Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers, 10.1158/1078-0432.ccr-07-4839
  181. Häyry V., Tynninen O., Haapasalo H. K., Wölfer J., Paulus W., Hasselblatt M., Sariola H., Paetau A., Sarna S., Niemelä M., Wartiovaara K., Nupponen N. N., Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours, 10.1111/j.1365-2990.2008.00949.x
  182. Chen Yu-Chih, Chang Charn-Jung, Hsu Han-Shui, Chen Yi-Wei, Tai Lung-Kuo, Tseng Ling-Ming, Chiou Guang-Yuh, Chang Shih-Ching, Kao Shou-Yen, Chiou Shih-Hwa, Lo Wen-Liang, Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1, 10.1016/j.oraloncology.2009.11.007
  183. Yan Hai, Parsons D. Williams, Jin Genglin, McLendon Roger, Rasheed B. Ahmed, Yuan Weishi, Kos Ivan, Batinic-Haberle Ines, Jones Siân, Riggins Gregory J., Friedman Henry, Friedman Allan, Reardon David, Herndon James, Kinzler Kenneth W., Velculescu Victor E., Vogelstein Bert, Bigner Darell D., IDH1andIDH2Mutations in Gliomas, 10.1056/nejmoa0808710
  184. Dang Lenny, White David W., Gross Stefan, Bennett Bryson D., Bittinger Mark A., Driggers Edward M., Fantin Valeria R., Jang Hyun Gyung, Jin Shengfang, Keenan Marie C., Marks Kevin M., Prins Robert M., Ward Patrick S., Yen Katharine E., Liau Linda M., Rabinowitz Joshua D., Cantley Lewis C., Thompson Craig B., Vander Heiden Matthew G., Su Shinsan M., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, 10.1038/nature08617
  185. Patel Jay P., Gönen Mithat, Figueroa Maria E., Fernandez Hugo, Sun Zhuoxin, Racevskis Janis, Van Vlierberghe Pieter, Dolgalev Igor, Thomas Sabrena, Aminova Olga, Huberman Kety, Cheng Janice, Viale Agnes, Socci Nicholas D., Heguy Adriana, Cherry Athena, Vance Gail, Higgins Rodney R., Ketterling Rhett P., Gallagher Robert E., Litzow Mark, van den Brink Marcel R.M., Lazarus Hillard M., Rowe Jacob M., Luger Selina, Ferrando Adolfo, Paietta Elisabeth, Tallman Martin S., Melnick Ari, Abdel-Wahab Omar, Levine Ross L., Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia, 10.1056/nejmoa1112304
  186. Kim Y.-H., Pierscianek D., Mittelbronn M., Vital A., Mariani L., Hasselblatt M., Ohgaki H., TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations, 10.1136/jclinpath-2011-200133
  187. Delhommeau François, Dupont Sabrina, Valle Véronique Della, James Chloé, Trannoy Severine, Massé Aline, Kosmider Olivier, Le Couedic Jean-Pierre, Robert Fabienne, Alberdi Antonio, Lécluse Yann, Plo Isabelle, Dreyfus François J., Marzac Christophe, Casadevall Nicole, Lacombe Catherine, Romana Serge P., Dessen Philippe, Soulier Jean, Viguié Franck, Fontenay Michaela, Vainchenker William, Bernard Olivier A., Mutation inTET2in Myeloid Cancers, 10.1056/nejmoa0810069
  188. Schwartzentruber Jeremy, Korshunov Andrey, Liu Xiao-Yang, Jones David T. W., Pfaff Elke, Jacob Karine, Sturm Dominik, Fontebasso Adam M., Quang Dong-Anh Khuong, Tönjes Martje, Hovestadt Volker, Albrecht Steffen, Kool Marcel, Nantel Andre, Konermann Carolin, Lindroth Anders, Jäger Natalie, Rausch Tobias, Ryzhova Marina, Korbel Jan O., Hielscher Thomas, Hauser Peter, Garami Miklos, Klekner Almos, Bognar Laszlo, Ebinger Martin, Schuhmann Martin U., Scheurlen Wolfram, Pekrun Arnulf, Frühwald Michael C., Roggendorf Wolfgang, Kramm Christoph, Dürken Matthias, Atkinson Jeffrey, Lepage Pierre, Montpetit Alexandre, Zakrzewska Magdalena, Zakrzewski Krzystof, Liberski Pawel P., Dong Zhifeng, Siegel Peter, Kulozik Andreas E., Zapatka Marc, Guha Abhijit, Malkin David, Felsberg Jörg, Reifenberger Guido, von Deimling Andreas, Ichimura Koichi, Collins V. Peter, Witt Hendrik, Milde Till, Witt Olaf, Zhang Cindy, Castelo-Branco Pedro, Lichter Peter, Faury Damien, Tabori Uri, Plass Christoph, Majewski Jacek, Pfister Stefan M., Jabado Nada, Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma, 10.1038/nature10833
  189. Jiao Y., Shi C., Edil B. H., de Wilde R. F., Klimstra D. S., Maitra A., Schulick R. D., Tang L. H., Wolfgang C. L., Choti M. A., Velculescu V. E., Diaz L. A., Vogelstein B., Kinzler K. W., Hruban R. H., Papadopoulos N., DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors, 10.1126/science.1200609
  190. Sturm Dominik, Witt Hendrik, Hovestadt Volker, Khuong-Quang Dong-Anh, Jones David T.W., Konermann Carolin, Pfaff Elke, Tönjes Martje, Sill Martin, Bender Sebastian, Kool Marcel, Zapatka Marc, Becker Natalia, Zucknick Manuela, Hielscher Thomas, Liu Xiao-Yang, Fontebasso Adam M., Ryzhova Marina, Albrecht Steffen, Jacob Karine, Wolter Marietta, Ebinger Martin, Schuhmann Martin U., van Meter Timothy, Frühwald Michael C., Hauch Holger, Pekrun Arnulf, Radlwimmer Bernhard, Niehues Tim, von Komorowski Gregor, Dürken Matthias, Kulozik Andreas E., Madden Jenny, Donson Andrew, Foreman Nicholas K., Drissi Rachid, Fouladi Maryam, Scheurlen Wolfram, von Deimling Andreas, Monoranu Camelia, Roggendorf Wolfgang, Herold-Mende Christel, Unterberg Andreas, Kramm Christof M., Felsberg Jörg, Hartmann Christian, Wiestler Benedikt, Wick Wolfgang, Milde Till, Witt Olaf, Lindroth Anders M., Schwartzentruber Jeremy, Faury Damien, Fleming Adam, Zakrzewska Magdalena, Liberski Pawel P., Zakrzewski Krzysztof, Hauser Peter, Garami Miklos, Klekner Almos, Bognar Laszlo, Morrissy Sorana, Cavalli Florence, Taylor Michael D., van Sluis Peter, Koster Jan, Versteeg Rogier, Volckmann Richard, Mikkelsen Tom, Aldape Kenneth, Reifenberger Guido, Collins V. Peter, Majewski Jacek, Korshunov Andrey, Lichter Peter, Plass Christoph, Jabado Nada, Pfister Stefan M., Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma, 10.1016/j.ccr.2012.08.024
  191. Lino Maria Maddalena, Merlo Adrian, Boulay Jean-Louis, Notch signaling in glioblastoma: a developmental drug target?, 10.1186/1741-7015-8-72
  192. Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert H K, Fussel M, Bachmann M, Rieber E P, Weigle B, Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy, 10.1038/sj.bjc.6603696
  193. Xin, Chin Med J (Engl), 124, 3515 (2011)
  194. Rao Ganesh, Pedone Carolyn A., Coffin Cheryl M., Holland Eric C., Fults Daniel W., c-Myc Enhances Sonic Hedgehog-Induced Medulloblastoma Formation from Nestin-Expressing Neural Progenitors in Mice, 10.1016/s1476-5586(03)80052-0
  195. Meletis K., p53 suppresses the self-renewal of adult neural stem cells, 10.1242/dev.02208
  196. Liu Xiangrong, Wang Lei, Zhao Shangfeng, Ji Xunming, Luo Yumin, Ling Feng, β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells, 10.1007/s12032-010-9476-5
  197. Larysz, Folia Neuropathol, 49, 28 (2011)
  198. Jung Gyung-Ah, Yoon Ju-Yong, Moon Byoung-San, Yang Dong-Hwa, Kim Hyun-Yi, Lee Sang-Hun, Bryja Vitezslav, Arenas Ernest, Choi Kang-Yell, Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway, 10.1186/1471-2121-9-66
  199. Molofsky Anna V., Pardal Ricardo, Iwashita Toshihide, Park In-Kyung, Clarke Michael F., Morrison Sean J., Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation, 10.1038/nature02060
  200. Garner Jo Meagan, Fan Meiyun, Yang Chuan He, Du Ziyun, Sims Michelle, Davidoff Andrew M., Pfeffer Lawrence M., Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway, 10.1074/jbc.m113.477950
Bibliographic reference Cruceru, Maria Linda ; Neagu, Monica ; Demoulin, Jean-Baptiste ; Constantinescu, Stefan N.. Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.. In: Journal of Cellular and Molecular Medicine, Vol. 17, no.10, p. 1218-35 (2013)
Permanent URL http://hdl.handle.net/2078.1/141174